#lundbeck

Drug Class:

NMDA (glutamate) Receptor Antagonist

Indications:

Alzheimer's disease (moderate-severe)

Doses:

10mg tablet

20mg tablet

Manufacturer:

Lundbeck A/S

Drug Store:

Abu Sharif Medical Stores

Contraindications:

Lennox-Gastaut Syndrome Awareness Day to Kick Off Epilepsy Awareness Month

Press Release – Oct 26, 2016 Bohemia, NY, October 26, 2016 (Newswire.com) – November 1st is the annual worldwide observance of Lennox- Gastaut Syndrome (LGS), a rare and severe form of epilepsy. This weekend, the LGS Foundation, the leading organization in the world dedicated to Lennox-Gastaut Syndrome, is hosting their signature awareness event in advance of epilepsy awareness month and LGS…

Requistion ID:  1511 Location:  Copenhagen, Hovedstaden Principal Bioinformatician – Bioinformatics Department Lundbeck’s passion links to our purpose about restoring brain health so every person can be their best. We strive to make a real difference to patients. By developing innovative treatments, we improve the lives of people living with brain diseases. Your dedication is crucial. That is…

Research Technician or Scientist in the Department of Circuit Biology

Requistion ID:  887 Location:  Copenhagen, N/A, DK Date:  10-Jan-2020  

Requistion ID:  844 Location:  Copenhagen, N/A, DK Date:  20-Dec-2019  

Lundbeck to acquire Alder BioPharmaceuticals for $1.95 billion; Alder stock hits new 52-week high

Denmark-based biopharma company Lundbeck announced today that it will acquire Alder BioPharmaceuticals (NASDAQ: ALDR) for $1.95 billion. Alder stock, which reached a new 52-week high ($18.88) in the morning session, rallied 83.9% to $18.50 when the market ended today. The Danish pharma company expects to strengthen its specialization in brain disesases with this transaction, which is estimated to…